Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Okapi Sciences
Leuven, Belgium
- Ownership
- Private
- Development stage
- Other
01
Overview
Developed antiviral small molecule therapeutics for pets; lead candidate for feline herpes virus ocular disease licensed to Novartis Animal Health prior to acquisition.
- Therapeutic areas
- OphthalmologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Veterinary
02
Partnerships
Novartis Animal HealthKU Leuven Rega Institute
Beyond the preview
Go deeper on Okapi Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Okapi Sciences.